Search PubMed⌕ Search

Biomedical subjects

M Rundell

Publications and source records attributed to M Rundell.

4 recordsLinked to original sources

Isolating antigenotoxic components and cancer cell growth suppressors from agricultural by-products.

Commercial processing wastes or by-products of crops were found to be sources of antimutagens and human tumor cell growth suppressors. We developed a microplate method to measure genomic DNA damage in Chinese hamster ovary cells with a modified single cell gel electrophoresis (SCGE) assay. This allowed us to measure the repression of 2-acetoxyacetylaminofluorene (2AAAF)-induced DNA damage by very small amounts of complex mixtures, fractions or individual chemicals isolated from agricultural by-products. We previously demonstrated that PCC, an ethanol extract of a commercial soybean processing by-product, repressed induced genomic DNA damage in mammalian cells. PCC was separated into a series of chemically defined fractions and two fractions (PCC70 and PCC100) repressed mutagen-induced damage. Of the isoflavones isolated from soybean fraction PCC70, daidzein expressed antigenotoxic activity, however, genistin and genistein enhanced DNA damage. An antigenotoxic response also was observed with a fraction isolated from corn distillate solids (CDS40). We developed a microplate assay to measure the suppression of the growth rate of human cancer cells in which the cytostatic/cytotoxic status at each concentration of the test sample was quantitatively determined. Genistein, genistin, daidzein and daidzin isolated from soybean fraction PCC70 expressed a wide range of growth suppression of HT-29 human colon cancer cells. The biological assays were integrated with, and directed, the separation and analytical chemistry component of this project. Compounds were purified from biologically active fractions and the structure of individual chemicals was determined with analytical HPLC and LC-mass spectroscopy (LC-MS). This research may lead to the isolation of novel chemoprotectants from agronomic commercial processing products and by-products.

Animals↗

Laparoscopic myomectomy in the infertile woman.

STUDY OBJECTIVE: To compare the outcome of the procedure we developed for laparoscopic myomectomy with outcomes reported in the literature for open and laparoscopic myomectomies. DESIGN: Prospective trial. SETTING: Lutheran General Hospital, Park Ridge, IL. PATIENTS: Forty-one consecutive infertile women who met selection criteria that were based on our experience with 15 initial laparoscopic myomectomies. INTERVENTION: Laparoscopic myomectomy. MEASUREMENTS AND MAIN RESULTS: Laparoscopic myomectomy was attempted in 41 and completed successfully in 40 women with minimal blood loss. Beyond the single conversion there were no major complications. The pregnancy rate within a year of the procedure was 75% (30 women) and viable term delivery rate was 65% (26 women). CONCLUSIONS: Pregnancy and viable term delivery rates compared favorably with those after open myomectomy procedures. Laparoscopic myomectomy was effective for selected patients experiencing infertility.

Female↗

Leiomyosarcoma of the scrotum: a case report with electron microscopy.

A case of leiomyosarcoma of the scrotum is presented. The tumor measured 3 X 2.5 X 2 cm and had been present as a slowly enlarging mass in the right scrotum for three months prior to excision. Light microscopy demonstrated the typical interlacing fasicles of neoplastic cells with eccentric cigar-shaped nuclei and electron microscopy confirmed the neoplastic cells to be of smooth muscle origin. A review of the world's literature revealed this to be the fifth reported case of leimyosarcoma confined to the scrotal wall.

Adult↗